Odaily Planet Daily News: Yahoo Finance quotes show that the stock price of South Korean biotechnology company Bridge Biotherapeutics, Inc. rose 20.59% today, with a market capitalization of 49.218 billion Korean won, approximately 36 million US dollars. Previously, it was reported that Bitcoin investment company Parataxis Holdings LLC announced it had reached a final investment agreement of 25 billion Korean won with Bridge Biotherapeutics, Inc., which gives it controlling interest in the latter. After the transaction is completed, Bridge Biotherapeutics will be renamed Parataxis Korea and will continue to be listed on the KOSDAQ market in South Korea.